02 December 2024
SOLASTA Bio completes $14m Series A to accelerate nature-inspired crop protection
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round to accelerate the development of its unique peptide-based, nature-inspired bioinsecticides – the first of their kind to be developed worldwide.
https://www.scottish-enterprise-mediacentre.com/news/solasta-bio-completes-usd-14m-series-a-to-accelerate-nature-inspired-crop-protection: SOLASTA Bio completes $14m Series A to accelerate nature-inspired crop protectionMore articles
22 October 2025
ABIM 2025 Workshop: Peptide Regulation
Basel, Switzerland: SOLASTA's Chief Strategy Officer, Paula Pinto; Panelist at Annual Biocontrol Industry Meeting 2025 Peptide Regulation Session International Biocontrol Manufacturers Association (IBMA) is actively engaged in promoting innovative biocontrol solutions, ...
20 June 2025
BBSRC Impact Showcase 2025 – SOLASTA Bio Feature
In 2019, Professor Shireen Davies, SOLASTA® Bio’s CEO, was awarded a Biotechnology and Biological Research Council (BBSRC) Royal Society of Edinburgh Enterprise Fellowship. This provided support for the commercialisation of ...